EVELO BIOSCIENCES (EVLO) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 47 sessions, October 6, 2025 to October 6, 2026
- Largest daily move
- +400% close of December 19, 2025
- 1-year change
- -60% closing prices, October 6, 2025 to October 6, 2026
- 1-month change
- +100% closing prices, August 27, 2026 to October 6, 2026
Company Description
EVELO BIOSCIENCES (OTC: EVLO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $9.5K.
EVLO has declined 60.0% over the past year. The last closing price was $0.0002.
For FY2022, EVELO BIOSCIENCES reported net income of -$114.5M and diluted earnings per share of -$1.31.
This page collects what Stock Titan holds for EVLO, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
EVELO BIOSCIENCES (EVLO) closed at $0.0002 on October 6, 2026. Over the past 12 months, the price has lost 60.0%.
EVLO Metrics & Rankings
Price returns through October 6, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
EVELO BIOSCIENCES has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, private placement, stock split, conferences. View all EVLO news →
SEC Filings
Financial Highlights
operating income reached -$108.5M, and net income was -$114.5M. Diluted earnings per share stood at -$1.31. The company generated -$101.2M in operating cash flow. The current ratio was 4.16, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in EVELO BIOSCIENCES (EVLO) currently stands at 6.7 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for EVELO BIOSCIENCES (EVLO) currently stands at 39.1 days, down 71.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 1857.5%. Across the settlements charted above, it has ranged from 1.0 to 156.7 days.
EVLO Company Profile & Sector Positioning
EVELO BIOSCIENCES (EVLO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing EVLO often look at related companies in the same sector, including SCOPUS BIOPHARMA INC (SCPS), RENOVACARE INC (RCAR), VIRPAX PHARMS INC (VRPX), STATERA BIOPHARMA INC (STAB), and Q BIOMED INC. (QBIO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EVLO's relative position within its industry.